GSK1016790A

GSK1016790A is a potent and selective agonist of the TRPV4 ion channel. It is commonly used in scientific research to study the physiological and pathological roles of TRPV4 channels in various tissues.
Chemical Properties[edit]
GSK1016790A is a small molecule with a complex chemical structure. It is known for its high affinity and specificity towards the TRPV4 channel, making it a valuable tool in pharmacology and neuroscience research.
Mechanism of Action[edit]
GSK1016790A activates the TRPV4 channel, which is a member of the TRP family of ion channels. TRPV4 channels are permeable to calcium and other cations, and their activation leads to an influx of these ions into the cell. This can result in various cellular responses, including changes in cell volume, inflammation, and pain perception.
Applications in Research[edit]
GSK1016790A is widely used in research to investigate the role of TRPV4 channels in different physiological and pathological processes. Some of the key areas of research include:
- Pain: TRPV4 channels are involved in the sensation of pain, and GSK1016790A is used to study their role in nociception and hyperalgesia.
- Inflammation: Activation of TRPV4 channels can lead to inflammatory responses, and GSK1016790A is used to explore these mechanisms.
- Cardiovascular system: TRPV4 channels are expressed in the endothelium and smooth muscle cells of blood vessels, and GSK1016790A is used to study their role in vascular tone and blood pressure regulation.
- Respiratory system: TRPV4 channels are present in the lungs, and GSK1016790A is used to investigate their role in pulmonary function and respiratory diseases.
Safety and Handling[edit]
As with any research chemical, proper safety protocols should be followed when handling GSK1016790A. It should be used in a controlled laboratory environment, and appropriate personal protective equipment (PPE) should be worn.
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian